• Miguel Ángel Lara Álvarez, Jacobo Rogado Revuelta, Berta Obispo Portero, Cristina Pangua Méndez, Gloria Serrano Montero, and Ana López Alfonso.
• Sección de Oncología Médica, Hospital Universitario Infanta Leonor, Madrid, España; Universidad Complutense de Madrid, Madrid, España. Electronic address: lara.miguelangel@gmail.com.
• Med Clin (Barc). 2020 Sep 11; 155 (5): 202-204.

Background And ObjectiveThe covid-19 pandemic especially affects cancer patients with higher incidence and mortality according to published series of original pandemic foci. The study aims to determine the mortality in our center due to covid-19 in cancer patients during the first 3 weeks of the epidemic.Material And MethodsThe cancer patients who died of covid-19 during the analysis period have been reviewed describing the oncological and the covid-19 infection characteristics and the treatments established.ResultsConfirmed cases covid-19: 1069 with 132 deaths (12.3%). With cancer 36 patients (3.4%), 15 deceased (41.6%). Of the deceased, only 6 patients (40%) were in active treatment. The most frequent associated tumor was lung (8/15 patients, 53.3%), 11 with metastatic disease (11/15, 73.3%). No specific treatment was established in 40% (6/15) of the patients. The rest of them received treatments with the active protocols.ConclusionCovid-19 mortality in cancer patients is almost four times higher than that of the general population. Until we have effective treatments or an effective vaccine, the only possibility to protect our patients is to prevent the infection with the appropriate measures.Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

36 keywords...

hide…